- William Hamilton, consultant senior lecturer1,
- Tim J Peters, professor1,
- Deborah Sharp, professor1
- 1NIHR School for Primary Care Research, Department of Community Based Medicine, University of Bristol, Bristol BS8 2AA
- w.hamilton{at}bristol.ac.uk
We are glad Wheatley agrees that general practitioners would appreciate reliable information on the predictive values of symptoms of ovarian cancer—that is what our study set out to do.1 2 He is concerned about the non-specific nature of the symptoms we identified. It certainly would be simpler if there were a symptom with high sensitivity and specificity for ovarian cancer, but none exists. …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012